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Purpose: Visually guided ocular growth is facilitated by scleral extracellular matrix remodeling at the posterior pole of
the eye. Coincident with scleral remodeling, significant changes in choroidal morphology, blood flow, and protein
synthesis have been shown to occur in eyes undergoing ocular growth changes. The current study is designed to identify
gene expression changes that may occur in the choroid/retinal pigment epithelium (RPE) of marmoset eyes during their
compensation for hyperopic defocus as compared to eyes compensating for myopic defocus.
Methods: Total RNA was isolated from choroid/RPE from four common marmosets (Callithrix jacchus) undergoing
binocular lens treatment using extended wear soft contact lenses of equal magnitude but opposite sign (±5 diopter [D]).
After reverse transcription, cDNA was labeled and hybridized to a human oligonucleotide microarray and gene transcript
expression profiles were determined. Real-time polymerase chain reaction (PCR) and western blot analysis were used to
confirm genes and proteins of interest, respectively.
Results: Microarray analyses in choroid/RPE indicated 204 genes were significantly changed in minus lens-treated as
compared with plus lens-treated eyes (p<0.05, Student’s t-test). Differential choroid/RPE expression of protein tyrosine
phosphatase, receptor type, B (PTPRB), transforming growth factor beta-induced (TGFBI), and basic fibroblast growth
factor 2 (FGF-2) were confirmed by real-time PCR. TGFBIp was confirmed at the protein level by western blot analysis
in marmoset and human cornea, choroid/RPE, and sclera.
Conclusions: The present study demonstrated that significant gene expression changes occur in the marmoset choroid/
RPE during visually guided ocular growth. The identification of novel candidate genes in choroid/RPE of marmoset eyes
actively accelerating or decelerating their rates of ocular elongation may elucidate the choroidal response during the
regulation of postnatal ocular growth and may lead to the identification of choroid/RPE signaling molecules that participate
in scleral remodeling.
Myopia is a common abnormal visual condition in which
the eye is too long for its optical power, resulting in the focal
plane being located in front of the retina. Generally, vitreous
chamber elongation stabilizes after puberty; however it fails
to stabilize in some cases. As a result of increased ocular
elongation, the retina thins and stretches to cover the eye
which can result in retinal detachment leading to blindness in
extreme cases [1]. Animal models of myopia have provided
significant  insights  into  the  cellular  and  molecular  events
underlying the control of ocular elongation and the refractive
state.  Depriving  the  retina  of  form  vision  by  lid  suture,
translucent occluders, or by imposing hyperopic defocus with
the use of negative power concave (minus) lenses [2,3] results
in an accelerated rate of axial elongation and the development
of myopia. In contrast, exposure to myopic defocus, as a result
of  restoration  of  unrestricted  vision  in  previously  form-
deprived eyes (recovery), or treatment with positive power
Correspondence  to:  Jody  Summers  Rada,  Department  of  Cell
Biology,  University  of  Oklahoma  Health  Science  Center,  940
Stanton L. Young Blvd., Oklahoma City, OK, 73104; Phone: (405)
271-3486;  FAX:  (405)  271-3548;  email:  jody-
summersrada@ouhsc.edu
convex (plus) lenses results in a decelerated rate of axial
elongation and hyperopia as compared with the contralateral
untreated  eye.  Significant  changes  in  scleral  extracellular
matrix synthesis, accumulation and turnover are associated
with changes in vitreous chamber elongation rates during the
development of experimentally induced myopia or hyperopia
in a variety of animals [4]. Changes in scleral proteoglycan
synthesis  [4,5],  matrix  metalloproteinase-2  activity  [6-8],
collagen synthesis, the rate of collagen degradation [5,9], and
changes in expression in transforming growth factor-β (TGF-
β) 1, 2, and 3 [8,10,11] have all been identified to occur in
scleras during visually induced changes in ocular growth.
Although the mechanisms underlying visually guided changes
in ocular elongation have yet to be determined, it is widely
accepted that local factors play an important role in these
sclera remodeling events [12].
The  choroid  is  the  highly  vascularized  layer  located
between the retina and the sclera, and has been implicated in
the regulation of scleral metabolism. Studies have shown that
the chick choroid undergoes a rapid and dramatic increase in
thickness during the recovery from induced myopia [13,14].
Similar, but much smaller choroidal thickness changes have
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1465been demonstrated in marmoset and macaque eyes recovering
from experimental myopia [15,16]. These thickness changes
may be the result of changes in choroidal blood flow [17] and
vascular permeability [18-20]; changes in the production of
osmotically active molecules, such as glycosaminoglycans,
that  draw  water  into  lymphatic  lacunae  present  in  the
choroidal stroma [13,21]; or by the contraction and relaxation
of  nonvascular  smooth  muscle  cells  present  within  the
choroidal stroma [22,23]. It is hypothesized that choroidal
thickening is a rapid mechanism for reducing myopia, by
pushing the retina to the focal point [13]. Concomitant with
choroidal thickening, the rate of vitreous chamber elongation
slows dramatically as scleral proteoglycan synthesis changes
[24].  Moreover,  suprachoroidal  fluid  removed  from  eyes
undergoing  recovery  following  experimentally  induced
myopic  defocus  inhibits  scleral  proteoglycan  synthesis  in
vitro as compared with that of fluid isolated from control
choroids [20].
It  has  also  been  recently  shown  that  significant
differences  in  RPE  gene  expression  are  associated  with
imposed +10 D and −10 D defocus in chicks and that some of
these gene expression changes might modulate the growth of
the choroid and sclera in young chick eyes [25]. Based on
these observations, we hypothesize that changes in choroid/
RPE gene expression occur during visually guided ocular
growth. These gene expression changes may be responsible
for mediating the choroidal response to optical defocus, as
well as for the regulation of scleral matrix remodeling and the
rate of vitreous chamber elongation.
In an effort to characterize the molecular mechanisms
involved in the response to visually induced changes in ocular
growth, we induced interocular growth rate differences and
anisometropia in young marmosets (Callithrix jacchus) using
binocular lenses of the same power but opposite sign (±5 D).
Microarray analyses were then used to identify differences in
gene expression in choroid/RPE from minus lens-treated eyes
as compared with that from plus lens-treated eyes as a first
step to uncovering novel choroid/RPE proteins involved in
mediating  scleral  extracellular  matrix  remodeling  and  the
regulation of ocular growth. In this study, we report gene
expression  changes  and  identify  the  presence  of  a  novel
protein  in  the  choroid/RPE  of  marmoset  eyes  undergoing
active ocular elongation.
METHODS
Animals and tissue preparation: Marmosets were raised in the
animal care facility at the New England College of Optometry
(Boston,  MA)  according  to  United  States  Department  of
Agriculture standard for animal care and use and the ARVO
Statement for the Use of Animals in Ophthalmic and Vision
Research.  Artificial  lighting  was  provided  using  daylight-
balanced  fluorescent  lamps  (Durotest  Vita-Light,
Philadelphia, PA) on a 12h:12h light-dark cycle. Interocular
growth  differences  were  maximized  by  raising  juvenile
marmosets (n=4) with extended wear soft contact lenses of
equal magnitude but opposite sign (±5 D). All four marmosets
(A, B, C, and D) wore lenses for 92 days beginning at either
60 days old (A and B) or 62 days old (C and D). Lenses were
removed  daily  at  the  beginning  of  the  dark  period,  and
replaced  the  next  morning,  just  before  the  light  period.
Experimentally  induced  changes  in  refractive  state  were
measured by retinoscopy and Hartinger refractometry under
cycloplegia  with  1%  cyclopentolate,  and  reported  as  the
average  of  the  spherical  equivalents  from  both  measures.
Axial  length  changes  were  measured  with  A-scan
ultrasonography and reported as changes in vitreous chamber
depth [26]. Ocular growth and refractive measurements were
taken every two weeks, and animals were euthanized via an
intravenous injection of a lethal dose of pentobarbital (190 mg
pentobarbital/100 g) following 92 days of lens wear when it
was  apparent  that  vitreous  chamber  depth  and  ocular
refractions  were  substantially  different  in  the  minus  lens-
treated eye as compared to the contralateral plus lens-treated
eyes.. The choroid/RPE were dissected from the sclera and
retina,  and  placed  in  Modified  Eagle's  Medium  (MEM)
culture  medium  until  snap  frozen  (5–10  min  following
dissection). Retinas and choroid/RPE were immediately snap
frozen  in  liquid  nitrogen  and  shipped  on  dry  ice  to  Jody
Summers  Rada  at  the  University  of  Oklahoma  Health
Sciences Center (Oklahoma City, OK). Tissue was stored at
−80 °C until the time of RNA isolation.
RNA  isolation:  Total  RNA  was  isolated  from  the  entire
marmoset choroid/RPE using TRIZOL Reagent following the
standard protocol (Invitrogen, Carlsbad, CA) and RNeasy
MinElute CleanUp (Qiagen, Valencia, CA). Briefly, frozen
tissues were homogenized in 1 ml TRIZOL Reagent using a
VirTis homogenizer (Gardiner, NY) before a 5 min incubation
at room temperature and chloroform treatment (200 μl) for
dissociation  of  nucleoprotein  complexes.  The  tubes  were
vigorously  shaken  by  hand  for  15  min  before  they  were
incubated at room temperature for 2 min. The upper aqueous
(RNA)  phase  was  collected  following  centrifugation
(12,000x g for 15 min at 4 °C). The aqueous phase was then
collected into a fresh tube then precipitated into a gel-like
pellet with 500 μl isopropyl alcohol by incubating for 10 min
at room temperature and centrifuging 12,000x g for 15 min at
4 °C. After removal of the supernatant, the RNA pellet was
washed  once  with  1  ml  75%  ETOH  by  centrifugation  at
7500x g for 5 min at 4 °C. The RNA pellet was dried by air
for 10 min before redissolving the RNA in 100 μl RNase-free
water and incubating for 10 min at 60 °C. RNA was stored at
−80  °C  until  use.  RNA  concentration  and  purity  was
determined at an optical density ratio of 260/280 using the
Nanodrop®  ND-1000  spectrophotometer  (NanoDrop
Technologies,  Wilmington,  DE)  and  then  transferred  for
microarray analysis to the Facility for Molecular and Cellular
Studies of Human Disease at the University of Oklahoma
Health Science Center.
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shipping on the quality of marmoset ocular RNA, total RNA
was extracted from the left and right retinas of subject A and
was assessed on a RNA 6000 Nano LabChip® kit using an
Agilent 2100 bioanalyzer (Agilent Technologies, Inc., Santa
Clara,  CA;  Laboratory  for  Genomics  and  Bioinformatics
Sequencing Core Facility, University of Oklahoma Health
Science  Center)  by  microcapillary  electrophoretic  RNA
separation.
Microarray:  To  date,  no  microarray  platform  is  available
using marmoset DNA sequences. Therefore, we used a human
cDNA  plastic  array  (Atlas™  Plastic  Human  12K  Array;
Clonetech Labs, Mountain View, CA), which used long (80
bp)  oligonucleotide  sequences  previously  characterized  in
terms  of  function  or  disease  association.  This  gene  array
contains 12,000 genes printed in duplicate on a plastic support
surface. Since the DNA sequence homology is relatively high
between  that  of  humans  and  marmosets  (85–97%
homologous) for a set of annotated genes [27], the use of a
long  oligonucleotide  array  allowed  for  the  detection  of
changes  in  expression  of  marmoset  genes  that  are  highly
homologous, yet not identical to that of humans.
cDNA probe synthesis from total RNA: Choroid/RPE RNA
was  digested  with  DNase  I  using  NucleoSpin  RNA  spin
columns (Clonetech Labs). α-33P radiolabeled cDNA probes
were  generated  from  total  RNA  using  random  primer
nucleotides together with PowerScript enzyme (Clonetech
Labs), according to the recommended protocol for the BD
Atlas Pure Total RNA Labeling System (BD Biosciences
Clontech, Heidelberg, Germany). Total RNA (1.55–3.27 μg)
for each pair of choroid/RPE's were used for right and left eyes
of  each  subject.  Briefly,  a  master  mix  (4  μl  5X  BD
PowerScript reaction buffer, 2μl 10X dNTP mix, 7  μl[α-33P]
dATP(>2,500 Ci/mmol, 10 μCi/μl),1.5μl 100mM DTT) was
prepared per reaction at room temperature. For each pair of
choroid/RPE, 1.55–3.27 μg of total RNA were combined and
gently mixed with 2 μl 100 μM N-15 (random primer mix)
and 1 μl cDNA synthesis control (1:200) for single-stranded
cDNA synthesis. The same amounts of starting RNA were
used for right and left eyes of each subject. Each reaction tube
was then incubated at 65 °C for 3 min, and then 42 °C for 2
min. After the addition of 2 μl/reaction PowerScript Reverse
Transcriptase to the master mix, 18.5 μl master mix/reaction
tube was added, then incubated at 42 °C for 30 min before
stopping the reaction by the addition of 3 μl 10X termination
mix. cDNA was purified from unincorporated nucleotides by
column  chromatography  (NucleoSpin  Extraction  Spin
column; (Clonetech Labs) and the radioactivity of the probes
was determined by scintillation counting.
Hybridizing cDNA probes to the Atlas array: Separate Atlas
arrays were used for cDNA probes generated from choroid/
RPE RNA from each of the eight marmoset choroid/RPE
RNA samples and placed in individual Atlas hybridization
boxes with equal amounts of 33P-labeled probe for the right
and left eyes of each marmoset. Atlas hybridization boxes
with equal amounts of 33P-labeled probe for the right and left
eyes  of  each  marmoset.  Specifically,  for  marmoset  A,
16x106  cpm  of  radiolabeled  cDNA  were  used  from  the
choroid/RPE probes from right and left eyes; for marmoset B,
13x106 cpm of radiolabeled cDNA were used; for marmoset
C, 13x106 cpm of radiolabeled cDNA were used; and for
marmoset D, 14x106 cpm of radiolabeled cDNA were used.
Plastic arrays were processed for probe hybridization and
washed at 68 °C according to the manufacturer’s protocols.
After careful removal of the membrane from the rinse, the
membranes were allowed to dry at room temperature and
placed on phosphorimaging screens (Molecular Dynamics,
Piscataway,  NJ)  for  a  72  h  exposure.  The  exposed
phosphorimaging  screens  were  digitized  using  a  Storm
Phosphorimaging System (Molecular Dynamics).
Array analysis: The expression levels of individual genes was
analyzed and compared (plus lens-treated eyes versus minus
lens-treated  eyes)  using  Array  Vision  Software  (Imaging
Research  Inc.,  Ontario,  Canada).  The  total  amount  of
hybridization signal emitted from each array locus (discrete
hybridization site) was reflected in the density of each array
locus on the membrane and expressed as “molecular dynamic
counts.” The background or nonspecific hybridization signal
was measured from negative DNA control loci on each plastic
array and subtracted from the signal of each individual locus.
The human 12,000 gene arrays consist of two spots on each
plastic  array,  and  the  mean  of  both  spots  following
background subtraction was calculated as the magnitude for
the expression of each gene. Gene expression changes were
compared between choroid/RPE's of minus lens-treated eyes
to  that  of  plus  lens-treated  eyes.  The  magnitude  of  each
corresponding gene was calculated and the relative difference
in signal of the minus lens-treated eyes to that of the plus lens-
treated eyes was expressed either as a ratio of the average
values: average Magnitude [minus lens]/average Magnitude
[plus lens] or as the difference of the average values: average
magnitude  [minus  lens]  –  average  Magnitude  [plus  lens].
Genes with significant expression differences between the
minus lens-treated eyes and plus lens-treated eyes for the four
marmosets were analyzed further for volcano plot and global
canonical  pathway  analyses.  Significant  differences  were
determined by Student's t-test using a p-value of ≤0.05.
Real-time polymerase chain reaction: The same RNA isolated
from  choroid/RPE  of  binocular  (aniso)  lens-treated
marmosets was used for real-time PCR analysis. cDNA was
generated from total RNA by reverse transcription and real-
time  PCR  was  performed  as  previously  described  [28].
Briefly, samples were run in triplicate using gene-specific
human  primers  together  with  SYBR  Green  (Molecular
Probes, Eugene, OR) in a 96 well plate format, using an i-
Cycler iQTM Multi-Color Real Time PCR Detection System
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1467(Bio-Rad, Hercules, CA). Primers were selected from human
sequences of characterized genes using BLAST, Primer3,and
Sigma-Genosys (St. Louis, MO), respectively. Primers used
in this study included TGF-β inducible gene-h3 (TGFBI; also
known as ßigh3, MP78/70, RGD-CAP, and keratoepithelin),
protein tyrosine phosphatase receptor-type B (PTPRB), and
basic fibroblast growth factor 2 (FGF-2). The cyclophilin A
gene,  peptidylprolyl  isomerase  A,  (PPIA),  was  used  as  a
control to normalize for variation in starting cDNA between
samples  (Table  1).  Human  primers  for  hypoxanthine
phosphoribosyltransferase  (HPRT)  and  glyceraldehyde  3
phosphate  dehydrogenase  (GAPDH)  were  also  tested  on
marmoset  cDNA  samples  from  choroid/RPE,  with
inconsistent results. On the other hand, the cyclophilin A
primers used in this study consistently generated high quality
PCR product with a high efficiency (Table 1). No consistent
differences in steady-state mRNA levels for cyclophilin A
were noted in our real time PCR analyses of cDNA from
marmoset choroid/RPE. Furthermore, while cyclophilin A
was not present on the Clontech microarray, cyclophilins B,
C, D, E, F, G, and H were present on the microarrays and were
not  significantly  different  in  choroid/RPE  of  minus  lens-
treated eyes as compared with that of plus lens-treated eyes.
Primer efficiencies were determined by the method of Pfaffl
[29] using marmoset choroid/RPE mRNA.
PCR  products  were  confirmed  by  DNA  sequencing
following  purification  on  quick  spin  columns  (Qiaquick;
Qiagen)  using  an  ABI  3730  capillary  DNA  sequencer
(Applied Biosystems, Foster City, CA, in collaboration with
the Laboratory for Genomics and Bioinformatics Sequencing
Core  Facility,  University  of  Oklahoma  Health  Science
Center).
Due to its relatively small size, sequencing of the FGF
PCR product required prior cloning into TOPO® vector using
pCR®2.1-TOPO-TA  cloning  kit  using  standard  protocols
(Invitrogen).  Briefly,  2  µl  TOPO®  Cloning  reaction  was
added to One Shot®TOP10 competent E. coli and transformed
by incubating the mixture on ice, followed by heat-shock at
42 °C. Transformed colonies were identified on ampicillin-
selective plates treated with 5-bromo-4-chloro-3-indolyl-b-
galactopyranoside (Xgal) and isopropylthio-B-D-galactoside
(IPTG) following overnight incubatation at 37 °C. Plasmid
DNA  was  purified  from  transformed  bacteria  using  the
Qiagen Plasmid Mini Kit (Qiagen tip-20; Qiagen) using the
recommended manufacturer’s protocol. Cloned PCR products
were  sequenced  using  M13  primers  provided  by  The
Laboratory  for  Genomics  and  Bioinformatics  Sequencing
Core Facility (University of Oklahoma Health Science Center,
Oklahoma City, OK).
Relative  levels  of  gene  expression  were  determined
between minus lens-treated and plus lens-treated eyes using
the mean normalized expression (MNE) values [30]. Correct
product  size  and  lack  of  primer  dimer  formation  was
confirmed  by  DNA  agarose-gel  electrophoresis  and  melt
curve analysis, respectively.
Western blot analysis: Total protein was extracted from the
cornea, choroid/RPE, sclera, and retina of both marmoset and
human eyes by vigorously mixing in 2% SDS, and 10 μl of
protein extracts were directly applied to 10% Bis-Tris Gel
NuPAGE™ SDS–PAGE gels (Invitrogen). Gel samples were
electrophoresed under reducing conditions and electroblotted
onto a nitrocellulose membrane using an electro-transfer unit
(XCELL  Sureback™  Electrophoresis  Cell;  Invitrogen)  or
stained with SimplyBlue™ SafeStain (Invitrogen) according
to the manufacturer’s instructions. Blots were probed with 100
μg  (1  mg/ml)  anti-hTGFBIp  affinity  purified  goat  IgG
antibody  (R&D  systems;  Minneapolis,  MN)  at  a  1:500
dilution in blocking buffer (PBS containing 0.1% Tween-20
and 0.2% I-Block [Tropix, Bedford, MA]) for 4 h at room
temperature. After washing, blots were incubated with rabbit
anti-goat  IgG  (whole-molecule)  conjugated  to  alkaline
phosphatase (Sigma, St. Louis, MO) at a dilution of 1:1000
for  1  h  at  room  temperature.  In  some  cases,  1  μM  anti-
hTGFBIp  was  pre-incubated  with  human  recombinant
TGFBIp  in  blocking  buffer  prior  to  use  in  western  blot
analyses.  Between  incubations  the  blot  was  washed  three
times for 10 min with PBS containing 0.05% Tween20. CDP-
Star  ®  Ready-to-Use  with  Nitro-BlockII™  (Tropix)  was
added to the blot for 5 min and then exposed on film.
Cell  attachment  assay:  Primary  human  scleral  fibroblasts
(HSFs) were prepared and maintained as previously reported
[28].  Briefly,  HSFs  were  cultured  on  100  mm  plates
TABLE 1. REAL –TIME PCR GENE PRIMERS, EFFICIENCIES AND HOMOLOGY OF THE MARMOSET PCR PRODUCT WITH THE HUMAN SEQUENCE
Gene
GenBank
accession
 number Primer sequence (5’-3’)
Product
Size
(bp)
Tm
(ºC)
Primer
efficiency
%
homology
Cyclophilin A NM_021130 F: TTT TCA TCT GCA CTG CCA AG 300 57.4 0.93 0.95
    R: GGA AAA CAT GGA ACC CAA AG
TGFBI M77349 F: GTC CAC AGC CAT TGA CCT TT 373 61 0.92 0.95
    R: GTC TCC CTT CAG GAC ATC CA
FGF-2 NM_002006 F: GGT GAA ACC CCG TCT CTA CA 172 55 0.93 0.78
    R: TCT GTT GCC TAG GCT GGA CT
PTPRB NM_002837 F: ACA TCC CTG GCA ACA ACT TC 323 60 0.94 0.97
    R: TGG CCA CAC CGT ATA GTG AA
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1468containing Dulbecco’s modified Eagle’s medium (DMEM)
containing  1X  antibiotic/antimycotic  (1X  a/a;  penicillin-
streptomycin/amphotericin B solution; Invitrogen) and 15%
fetal  bovine  serum  (FBS)  at  37  °C  with  5%  CO2.  After
reaching  confluency,  the  cells  were  detached  by  gentle
pipeting following incubation in 0.53 mM EDTA in Hank’s
balanced salt solution (HBSS; Sigma-Aldrich) and counted
using a hemocytometer.
For cell attachment assays, 50 μl protein (0-25 μg/ml;
BSA, fibronectin, or TGFBIp) in phosphate buffered saline
(PBS) was added to poly-D-lysine 96 well ProBind™ (Becton
Dickinson Labware, Franklin Lakes, NJ) plates in triplicate
and allowed to bind for 1 h at 37 °C/5% CO2. Next, 100 μl
HSFs (2x103 cells/well) were added to each well in serum-
limited  medium  (DMEM  with  1X  antibiotic/antimyotic
containing 0.5% FBS) for 45 min at 37 °C/5% CO2. The
unattached cells were gently removed by washing twice with
PBS, and then 100 μl hexosaminidase substrate (50 mM citrate
buffer, pH 5.0 with 3.75 mM N-acetyl-β-D-glucosaminidase
and 25% Triton-X-100) was added to each well for 1 h at
37 °C/5% CO2. Finally, 150 μl (50 mM) glycine buffer, pH
10.4, with 5 mM EDTA was added to each well to stop enzyme
activity, and the absorbance read at 405 nm.
Statistical analysis: Comparisons of ocular size and refraction
between plus lens-treated and minus lens-treated eyes were
made using the Student’s t-test for matched pairs with the
assistance  of  GraphPad  Prism  version  4.03  for  Windows
(GraphPad  Software,  San  Diego,  CA).  Patterns  of  gene
expression  and  differentially  expressed  genes  identified
through  microarray  experiments  were  analyzed  using
MultiExperiment  Viewer  version  4.0,  developed  and
maintained  by  the  team  at  Dana-Farber  Cancer  Institute
(Harvard University Medical School, Boston, MA). Statistical
comparisons of gene expression between minus lens-treated
and plus lens-treated eyes were conducted by use of paired
and unpaired Student’s t-tests using Array Vision Software
(Imaging Research Inc., Ontario, Canada).
Ingenuity  Pathways  Analysis  (Ingenuity  Systems,
Redwood City, CA) was used to identify canonical pathways
potentially involved in the choroidal and RPE response to both
minus  and  plus  lens  treatments.  The  Ingenuity  Pathways
Analysis  knowledge  database  (IPKB;  Ingenuity  Systems,
Redwood City, CA) is a database developed by review of peer
reviewed  journals  and  includes  information  for  proteins,
genes, protein-complexes, cells, cellular components, tissues,
organs, and disease interrelationships. The database currently
covers over 23,900 mammalian genes for human, mouse, and
rat and is updated quarterly. Genes that were significantly
upregulated or significantly downregulated (p≤0.05) in minus
lens-treated eyes as compared with plus lens-treated eyes were
subjected to canonical pathways analysis using the IPKB. The
significance value assigned to each function was calculated
using  the  right-tailed  Fischer’s  Exact  Test.  This  test
determines  the  chance  that  the  genes  of  interest  (the
significantly  upregulated  and  significantly  downregulated
genes in choroid/RPE of minus lens-treated eyes as compared
with plus lens-treated eyes) participate in known biologic
pathways from the Ingenuity Pathways Analysis library of
canonical pathways. Fischer’s exact test was used to calculate
a p-value, determining the probability that the association
between the genes in the data set and the canonical pathway
was explained by chance alone. Statistical significance of the
effect of TGFBI expression on scleral fibroblast attachment
was determined using the Student’s t-test.
Figure 1. Refractive state and vitreous chamber depth of marmoset
eyes following binocular +5 D and -5 D lens treatment over 92 days.
A: −5 D lens-treated eyes (open symbols) exhibited a more negative
refractive  error  relative  to  contralateral  +5  D  lens-treated  eyes
(closed  symbols).  B:  −5  D  lens-treated  eyes  (open  symbols)
exhibited longer vitreous chambers relative to contralateral +5 D
lens-treated  eyes  (closed  symbols).  Eyes  of  the  four  individual
marmosets are represented by different symbols (red circle, subject
A; green square, subject B; black triangle, subject C; blue diamond,
subject D).
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Binocular lens treatment: Binocular -5/+5 D lens treatment
resulted  in  distinct  interocular  differences  in  refractive
development  (Figure  1A)  and  vitreous  chamber  growth
(Figure 1B). Following 92 days of binocular lens treatment,
minus  lens-treated  eyes  had  significantly  more  myopia
(−6.545±0.787  D;  Figure  2A)  and  significantly  longer
vitreous chamber depth (6.750±0.0478 mm; Figure 2B) as
compared  with  contralateral  plus  lens-treated  eyes
(0.505±1.467 D and 6.354±0.116 mm; p<0.01 and p<0.05,
respectively; Student’s t-test). For comparison, interocular
differences in refraction (Figure 2A) and vitreous chamber
depth (Figure 2B) of age-matched untreated animals were
included and indicated as separate points. Examination of the
effective refractive state (refraction at different points during
the rearing period with the lenses in place) indicated that in
all  animals,  the  positive-lens-treated  eye  was  always
experiencing relative myopia compared to the negative-lens-
treated eye (data not shown). No significant changes were
detected in anterior chamber depth, lens thickness, corneal
curvature, or choroid thickness between minus lens-treated
and plus lens-treated eyes at the time of sacrifice.
RNA isolation: Using standard protocols, Trizol extraction of
choroid/RPE tissue from individual marmoset sets yielded
approximately 8-10 μg total RNA/eye of high purity (260/280
nm ratios of 1.96-2.08). Measurements of incorporated  33P
indicated that cDNA probe synthesis from total RNA of each
marmoset choroid/RPE was well within the optimal range
(5-25x106  cpm/5  μl)  following  purification  by  column
chromatography  for  microarray  analyses  (13-17x106  cpm/
5 μl). Moreover, electrophoretic analyses were carried out on
total RNA isolated from the left and right retinas of one pair
of  marmoset  eyes  (subject  A)  and  shipped  and  stored  in
parallel with the choroid/RPE samples. Intact 28S and 18S
rRNA  subunits  were  apparent  on  electropherograms,
suggesting that tissue isolation, storage and shipping were
suitable to maintain the integrity of mRNA isolated from
marmoset eyes used in this study (Figure 3).
Microarray analysis of marmoset choroid/RPE RNA: In an
effort to identify genes involved in the regulation of ocular
growth,  microarray  analysis  was  performed  to  compare
choroid/RPE  gene  expression  in  marmoset  (Callithrix
jacchus) eyes during treatment with +5 D lenses with that of
eyes during treatment with −5 D lenses. A total of 11,867
genes were evaluated in eight separate microarrays of plus
lens-treated and minus lens-treated eyes of four marmosets
using  MultiExperiment  Viewer  v.  4.0  [31].  Following
background subtraction, a total of 8,270–11,360 genes were
available  for  analysis  on  each  of  the  8  microarrays.
Comparison of differentially expressed genes between the
choroid/RPE of right and left eyes indicated that a total of 204
genes  were  significantly  upregulated  or  downregulated  in
minus lens-treated eyes as compared with plus lens-treated
eyes (p<0.05; Student’s t-test for unmatched pairs). Of these,
183 genes were significantly upregulated and 21 genes were
downregulated in minus lens-treated eyes as compared with
plus  lens-treated  eyes  (Figure  4).  Choroid/RPE  gene
expression differences between minus lens-treated and plus
lens-treated eyes, together with the Student’s t-test criteria
(p<0.05) were summarized by volcano plot analysis (Figure
4).  The  volcano  plot  served  as  a  visualization  tool  for
presentation  of  the  t-test  results  when  the  two  groups  of
samples  were  compared.  For  each  gene,  this  plot
demonstrated  the  log2  of  the  fold  change  in  the  average
expression of the two groups (+5 D lens-treated eyes and −5
D lens-treated eyes) as plotted against −log10(p). P represents
the probability value for a given gene which is associated with
the t-test comparison of the two groups of samples. Genes with
statistically significant differential expression according to
the  gene-specific  t-test  were  found  above  the  horizontal
threshold line of 1.3 (-log of p value=0.05). Genes with large
Figure 2. Interocular differences in ocular refraction and vitreous
chamber depth in −5 D lens-treated eyes and in contralateral +5 D
lens-treated  eyes  in  four  individual  marmosets.  For  comparison,
interocular differences in refraction (A) and vitreous chamber depth
(B) in two eyes of untreated normal animals (n=30) over the same
age range are indicated as dotted circles. Eyes of the four individual
marmosets are represented by different symbols (red circle, subject
A; green square, subject B; black triangle, subject C; blue diamond,
subject D).
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or  right  (upregulated  genes)  of  a  vertical  threshold  line.
Therefore, significantly upregulated or downregulated genes
identified by t-tests would be located in the upper left or upper
right parts of the plot.
Of the 204 differentially expressed genes, those non-
hypothetical genes with known functions were classified into
functional groups according to the Entrez Gene database and
literature review (Appendix 1). A total of 131 differentially
expressed genes were classified into 22 functional categories:
cell  receptors  (5%),  cell  signaling  and  extracellular
communication  proteins  (7%),  intracellular  transducers,
effectors,  and  modulators  (12%),  metabolism  (12%),  and
transcription  (14%).  Among  the  relatively  downregulated
genes were cell receptors, including PTPRB (p=0.0384), and
relatively upregulated genes included transcripts for growth
factors,  including  FGF-2  (p=0.0161),  and  TGFBI/βig-h3
(p=0.0395).
Global pathway analysis: Global canonical pathway analyses
were  employed  to  identify  the  cellular  mechanisms
underlying the ocular response to minus lens-induced and plus
Figure 3. Electropherograms of total RNA extracted from the retinas
of left and right marmoset eyes of subject A following microcapillary
electrophoresis. Electropherograms demonstrate well defined 18S
and 28S rRNA peaks indicating high quality RNA was extracted
from the retinas of left (A) and right (B) marmoset eyes. Since the
retinas were dissected and processed in parallel with the choroid/RPE
tissue used in the present study, these results suggest that the tissue
dissection, snap freezing, and shipping of tissues was adequate to
preserve high quality RNA. FU is fluorescence units.
lens-induced defocus. The 204 genes that were significantly
altered  in  their  expression  levels  (upregulated  and
downregulated)  during  lens  treatment  were  submitted  for
global  canonical  pathway  analysis  (Ingenuity  Pathways
Analysis,  Ingenuity  Systems).  Several  genes  that  showed
significant changes in gene expression in the choroid/RPE of
minus lens-treated eyes as compared with plus lens-treated
eyes  were  identified  in  Ingenuity’s  library  of  canonical
pathways (Figure 5). The significance calculated for each
canonical pathway is a measurement of the likelihood that the
pathway is associated with the upregulated or downregulated
genes by random chance. Five canonical pathways (toll-like
receptor signaling, lysine degradation, xenobiotic metabolism
signaling,  p38  mitogen-activated  protein  kinase  (MAPK)
signaling, and phenylalanine metabolism) showed significant
upregulation.  In  contrast,  stress-activated  protein  kinase
(SAPK)  and  c-Jun  NH2-terminal  kinase  (JNK)  signaling,
GABA receptor signaling, epidermal growth factor (EGF)
signaling, interleukin-2 (IL-2) signaling, hypoxia signaling,
Huntington disease signaling, cell cycle: G2/M DNA damage
Figure 4. Volcano plot of marmoset choroid/RPE microarray data.
Scatter plot represents a summary of the t-tests for the individual
genes. For each gene this plot shows log2 of fold change between the
mean expression in minus lens-treated group and plus lens-treated
group as plotted against −log10 (p), where p is a probability value (for
a given gene) which is associated with the Student t-test comparison
of the two groups of samples. Using a p value of 0.05 as the cutoff
threshold, 21 genes were significantly downregulated in minus lens-
treated eyes as compared with plus lens-treated eyes (negative log2)
and 183 genes were significantly uppregulated in minus lens-treated
eyes as compared with plus lens-treated eyes (positive log2). Each
point  represents  an  individual  gene  in  the  array;  genes  not
significantly  altered  are  depicted  in  black,  whereas  genes
significantly changed are indicated in red. Those genes appearing on
the upper left or right region have a large fold-change and a smaller
p value.
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showed significant downregulation. Hypoxia signaling in the
cardiovascular system and SAPK/JNK signaling pathways
were found to be the most significantly perturbed canonical
pathways (p<0.01) in minus lens-treated eyes as compared
with  plus  lens-treated  eyes.  These  results  suggest  that
molecular events characterized for these canonical pathways
may also be involved in mediating the choroid/RPE response
to visually induced changes in ocular growth.
Validation of genes of interest: To validate choroid/RPE gene
expression differences in minus lens-treated versus plus lens-
treated eyes undergoing changes in ocular growth rates, we
performed  quantitative  real-time  PCR  on  three  genes  of
interest.  Due  to  limitations  in  RNA  from  marmoset  lens-
treated eyes available for real-time PCR, genes were selected
based on their potential for regulating ocular growth and cell-
matrix  interactions  during  periods  of  accelerated  or
decelerated ocular growth (e.g., a secreted growth factor or
extracellular matrix molecule). Therefore, the significantly
upregulated  genes,  TGFBI  and  FGF-2,  were  selected  for
confirmation. Additionally the tyrosine phosphatase receptor,
PTPRB, was selected for real-time PCR experiments as this
was one of relatively few significantly downregulated genes
in the choroid/RPE of minus lens-treated eyes as compared
with plus lens-treated eyes. Using the same eight samples of
total  choroid/RPE  RNA  used  for  microarray  analyses,
quantitative real-time PCR analyses confirmed that PTPRB
was significantly downregulated in the choroid/RPE of minus
lens-treated  eyes  as  compared  with  plus  lens-treated  eyes
(−54.6%, p<0.05, paired t-test) while TGFBI and FGF-2 were
significantly upregulated in the choroid/RPE of minus lens-
treated eyes as compared with plus lens-treated eyes of the
four marmosets examined (+139.7%, +43.7%, respectively
p<0.05,  paired  t-test;  Figure  6).  DNA  gels  confirmed  the
correct primer size (Figure 7). Melt curve analyses confirmed
a lack of primer dimer formation and sequencing of the PCR
product confirmed amplification of the gene of interest (Table
1).
It should be noted that the magnitude of the differences
in gene expression observed on oligonucleotide microarrays
(Appendix 1) was substantially different as compared with
real-time PCR results. Numerous methodologic differences
can influence the magnitude of the changes in gene expression
observed on oligonucleotide microarrays and real-time PCR,
including different efficiencies of reverse transcriptases and
priming  methods  for  real  time  PCR  and  microarray
experiments and differences in data normalization between
microarray  analysis  and  real  time  PCR  [32].  It  was  the
Figure  6.  Real  time  polymerase  chain  reaction  quantification  of
differentially expressed genes in the marmoset choroid/RPE. The
expression of fibroblast growth factor-2 (A), transforming growth
factor beta induced (B), and protein tyrosine phosphatase, receptor
type, B (C) mRNA was measured using human gene-specific primers
(Appendix 1). Graphs represent the mean normalized expression of
each gene of interest in individual marmoset choroid/RPE samples
following minus or plus lens-treatment. All reactions were run in
triplicate and normalized to the reference gene, cyclophilin A.
Figure 5. Global canonical pathway analysis of significantly upregulated and downregulated genes in minus lens-treated eyes as compared
with plus lens-treated eyes. Data sets were analyzed by the Ingenuity Pathways Analysis software (Ingenuity® Systems). The significance is
expressed as a p value that is calculated using the right tailed Fisher exact test. Red and blue bars represent significantly upregulated and
downregulated genes associated with canonical pathways, respectively. In the figure, n represents the number of genes identified in each of
the pathways.
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regulated  genes  in  choroid/RPE  from  eyes  following
treatment  with  plus  and  minus  lenses  regardless  of  the
differences in magnitudes of the relative gene expression.
Using this approach, candidate genes may be identified that
are involved in the regulation of ocular growth.
Interestingly,  relative  gene  expression  changes  for
FGF-2 and PTPRB in subject D were lower than the other
three  subjects  and  subject  D  exhibited  the  most  negative
refractive error in the plus and minus lens-treated eyes at the
end of the 92-day lens treatment period (Figure 1). While these
data  suggest  that  subject  D  responded  differently  to  the
binocular  aniso  lens  treatment,  we  cannot  exclude  the
possibility that these responses are within the normal range of
variation. Changes in vitreous chamber depth (Figure 1B) and
TGFBI expression (Figure 6B) for subject D were similar to
that of the other three subjects.
Figure  7.  Real  time  polymerase  chain  reaction  (qRT-PCR)  of
choroid/RPE genes. Genes identified on microarrays as significantly
differentially expressed in choroid/RPE of minus lens-treated eyes
as compared with plus lens-treated eyes were assessed by qRT-PCR.
cDNA was prepared from total RNA extracted from choroid/RPE of
+5 D lens-treated (+) and −5 D lens-treated (-) eyes of subjects A, B,
C, and D. Human primers were used to amplify 172-373 bp regions
of cyclophilin A (cyclophilin), transforming growth factor, beta-
induced (TGFBI), 68 kDa, fibroblast growth factor -2 (FGF2), and
protein tyrosine phosphatase, receptor type, B (PTPRB; see Table 1).
Transforming growth factor β-induced protein in marmoset
choroid/RPE: Based on microarray and quantitative real-time
PCR results, TGFBI was selected for further study. This gene
was significantly upregulated in the choroid/RPE of minus
lens-treated eyes relative to plus lens-treated eyes and the
expressed protein, TGFBIp, has not been previously identified
in ocular tissues other than the cornea [33,34]. Western blot
analysis was used to examine the distribution of TGFBIp in
the cornea, choroid/RPE, and sclera of the marmoset (Figure
8A) and in the cornea, choroid/RPE, retina and sclera of the
human eye (Figure 8B). A single band of about 65 kDa could
be identified in marmoset protein extracts of cornea, choroid,
and sclera (Figure 8A, upper panel), which was abolished
following pre-incubation of primary antibody with human
recombinant  TGFBIp  (rTGFBIp  block;  Figure  8A,  center
panel), suggesting that these bands represent the TGFBIp
protein  in  these  tissues.  TGFBIp  was  not  detected  in  the
human or marmoset retina (Figures 8B and 8D). Western blot
analysis of human corneal extracts also demonstrated a major
TGFBIp-immunopositive band of about 65 kDa as well as a
minor band of about 51 kDa (Figure 8B, upper panel and
Figure 8C), while a 65-70 kDa doublet was apparent in scleral
extracts. A single band of about 65 kDa was apparent in human
choroidal extracts. The single 65 kDa bands as well as the
65-70 kDa doublets observed in human cornea, choroid and
scleral extracts were abolished following pre-incubation of
primary  antibody  with  human  recombinant  TGFBIp
(rTGFBIp block; Figure 8B, middle panel), suggesting that
these bands represent the TGFBIp protein in these tissues. The
doublet observed in the scleral sample most likely represented
the native and processed forms of TGFBIp, as described for
human neuroblastoma cells [35].
The effect of transforming growth factor β-induced protein on
scleral  fibroblast  cell  attachment:  Cell  attachment  assays
were used to gain insights on the functional significance of
increased TGFBI expression in the choroid/RPE of minus
lens-treated  eyes  relative  to  plus  lens-treated  eyes.  The
attachment  of  HSFs  to  poly-D-lysine-coated  plates  was
examined after treatment of wells with varying concentrations
of TGFBIp, fibronectin, and BSA (Figure 9). Pretreatment of
wells with TGFBIp at a concentration of 25 μg/ml (0.38 μM)
significantly  decreased  the  binding  of  human  scleral
fibroblasts, as compared with equivalent concentrations of
BSA (-70.7%; p<0.05) and fibronectin (-92.1%; p<0.001).
Cell attachment was slightly, but not significantly, inhibited
by TGFBIp at a concentration of 10 μg/ml as compared with
BSA  (-32.6%,  p=0.246).  In  contrast,  scleral  fibroblast
attachment to fibronectin substantially increased as compared
with equivalent concentrations of BSA (+93%, p<0.01 for 5
μg/ml; +158.9%, p<0.001 for 10 μg/ml, and 270.6%, p<0.01
for 25 μg/ml, respectively).
DISCUSSION
Changes  in  choroidal  thickness,  permeability,  and  protein
synthesis  are  associated  with  changes  in  visually  guided
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Moreover, co-culture of chick choroids or choroidal fluid with
chick sclera has indicated that the choroids release bioactive
factors  that  inhibit  scleral  proteoglycan  synthesis  [21,36].
Based on these observations, we hypothesized that changes in
choroid/RPE  gene  expression  were  responsible  for  the
production of secreted proteins that could regulate the rate of
scleral proteoglycan synthesis and ocular growth.
Microarray  platforms  (Atlas™  Plastic  Human  12K
Array,  Clonetech  Labs)  were  employed  to  identify  gene
expression profiles in choroid/RPE complexes isolated from
primate eyes treated with +5 D lenses as well as fellow eyes
treated  with  −5  D  lenses.  By  comparing  gene  expression
profiles  from  eyes  treated  with  +5  D  lenses  with  gene
expression  profiles  of  eyes  treated  with  −5  D  lenses,  we
anticipated  that  choroidal  genes  would  be  identified  in
marmosets that would help to elucidate choroidal and RPE
responses  to  imposed  defocus  and  could  lead  to  the
identification of choroidal and or RPE proteins that play a role
Figure 8. Transforming growth factor, beta-induced protein detection
in  marmoset  and  human  ocular  tissues.  Western  blot  analysis
identified the presence of transforming growth factor, beta-induced
protein (TGFBIp) in the cornea (Co), choroid/RPE (Cho), sclera
(Scl), and retina (Ret) of the marmoset (A) and human eye (B). Pre-
incubation of TGFBIp antibodies with recombinant TGFBIp protein
(rTGFBIp;  1  µM  final  concentration)  abolished  all  major  anti-
TGFBIp immunoreactive bands in marmoset tissue extracts, with the
exception of a faint band in the human cornea lane migrating at ≤ 65
kDa (B, center panel; rTGFBIp block). Total protein loaded in each
well was visualized by Coomassie Blue staining (A and B, bottom
panels). C: Lighter exposure of Figure 7B (top panel). Recombinant
TGFBIp protein (rTGFBIp, 40 ng) and cornea served as positive
controls.
in scleral extracellular matrix organization and the regulation
of ocular growth.
Binocular  +5/-5  D  lens  treatment  was  used  in  our
investigation to maximize differences in interocular growth
rates and the refractive states of the paired eyes to identify
changes in gene expression in choroid/RPE associated with
different  ocular  growth  states.  The  application  of  this
binocular lens paradigm has been well described and shown
to be both an effective and reproducible method to induce
anisometropia [37,38], which is greater than that observed
with monocular plus or minus lens treatment (unpublished).
In  the  present  study,  measurements  of  ocular  growth  and
refraction were made every two weeks which enabled us to
determine the rate of ocular growth in plus and minus lenses
throughout the treatment period. Following 92 days of lens
wear binocular +5/-5 D lens treatment resulted in distinct
anisometropia, with significantly higher negative refractive
errors and significantly longer vitreous chamber depths in
minus lens-treated eyes as compared with plus lens-treated
eyes.  Analyses  of  vitreous  chamber  depths  and  refractive
changes during this treatment period indicated that ocular
growth and refractive states had not stabilized in either the
positive lens-treated or negative lens-treated eyes following
92 days of lens wear. Lens-treated eyes continued to exhibit
changes in growth and refraction at the end of the 92 day
treatment period. Therefore, we cannot exclude the possibility
that choroid/RPE gene expression changes identified in this
Figure 9. Inhibition of cell attachment by transforming growth factor,
beta-induced protein. Solid-phase adhesion assay of primary human
scleral fibroblasts to wells pre-coated with 0-25 μg bovine serum
albumin (BSA), fibronectin (FN), and transforming growth factor,
beta-induced  protein  (TGFBIp)  on  poly-D-lysine  96-well  plates.
Cells were seeded 2000 cells/well and allowed to attach for 45 min
in serum-limiting media. Unattached cells were gently rinsed off and
remaining  attached  cells  were  quantified  by  measuring
hexosaminidase,  as  described  in  Methods.  Cell  attachment  was
significantly  decreased  in  wells  coated  with  25  μg  TGFBIp  as
compared to BSA controls. Data are expressed as the mean±SEM by
the  Student  t-test  for  unmatched  pairs  for  three  individual
experiments in triplicate. In the figure, the asterisk indicates p≤0.
05.
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resulting  from  aniso-lens  treatment,  or  represent  an
epiphenomenon,  i.e.,  as  a  consequence  of  lens-induced
changes in ocular growth.
While several recent reports have described changes in
retina and retina/RPE gene expression associated with the
development of myopia [25,39], no previous studies have
examined gene expression changes in the choroid and RPE
during  visually  induced  changes  in  ocular  growth.  In  the
present  study,  microarray  analysis  identified  204  (~1.7%)
genes that were significantly differentially expressed on an
11,867  gene  human  array.  The  majority  of  differentially
expressed genes (~90%) were upregulated in choroid/RPE's
of minus lens-treated eyes as compared to plus lens-treated
eyes (or downregulated in plus lens-treated eyes as compared
with  minus  lens-treated  eyes).  These  microarray  results
suggest that gene expression profiles of choroid/RPE from
plus lens-treated eyes are distinct from that of minus lens-
treated eyes, and differentially expressed genes are likely to
be relevant to the mechanism of ocular compensation for
induced refractive error.
Interestingly,  hypoxia  signaling  in  the  cardiovascular
system and SAPK and JNK signaling pathways were found to
be  the  most  significantly  perturbed  canonical  pathways
(p<0.01), due to significant downregulation of JUN (GenBank
J04111)  and  upregulation  of  tumor  protein  p53  (TP53;
GenBankM14694)  genes  in  choroid/RPE's  of  minus  lens-
treated eyes relative to expression levels in plus lens-treated
eyes.  Interestingly,  hypoxia-induced  activation  of  tumor-
related proteins such as extracellular signal-regulated kinase,
JNK, and p53 has been shown to be nitric oxide-mediated in
a variety of experimental systems [40,41]. Previous studies in
chicks have suggested that nitric oxide may be involved in the
choroidal response to myopic defocus, since treatment with
the  nitric  oxide  synthase  inhibitor,  L-NAME,  transiently
inhibited the expected increase in choroidal thickness [42].
Taken  together,  these  results  suggest  that  the  molecular
signaling pathways in the choroid/RPE associated with +5 D
lens-treatment may be similar to those involved in hypoxia-
induced signaling pathways.
In the present study, we examined the expression of genes
that have been previously implicated to play a role in myopia
development  or  have  been  previously  characterized  to  be
involved in cell-matrix interactions and extracellular matrix
remodeling.  Due  to  limited  mRNA  following  microarray
analysis only three genes (FGF-2, TGFBI, and PTPRB) were
reevaluated in the four individual marmosets by quantitative
real-time PCR. Although the magnitude of the expression
differences between plus and minus lens-treated eyes varied
between individual marmosets as well as that obtained from
microarray and real-time PCR results, significant changes in
the  expression  of  these  three  genes  were  detected  in  the
choroid/RPE of the four marmosets examined in this study.
FGF-2  is  a  pro-mitogenic  growth  factor  located  in
basement membranes and in the subendothelial extracellular
matrix of blood vessels and is involved in wound healing,
tumor formation, and angiogenesis [43,44]. FGF-2 mRNA
and protein expression have been previously described in the
retina [45,46], choroidal endothelial cells [47], and sclera
[46,48]. Studies in chicks have suggested that FGF-2 acts
together  with  TGF-β1  to  regulate  ocular  growth  [49,50],
possibly through the alteration of retinal circuitry that controls
postnatal ocular growth [51]. Although scleral and retinal
levels of FGF-2 have been reported to be unchanged during
the development of myopia or recovery from myopia in the
tree shrew, the expression of the FGF-2 receptor, FGFR-1, has
been shown to be upregulated in the sclera of myopic tree
shrew eyes and downregulated to control eye levels during
recovery, suggesting that FGF-2 plays a role in the control of
scleral  remodeling  during  visually  guided  ocular  growth
[48].  Taken  together,  these  results  and  the  results  of  the
present study suggest that FGF expression is altered in the
choroid/RPE during lens-induced changes in ocular growth
and may play a role in chemical cascades in the retina, choroid,
and sclera.
In  addition  to  FGF-2,  the  expression  of  the  TGFβ1-
inducible  gene  TGFBI  was  elevated  in  eyes  actively
elongating after minus lens-treatment, relative to that of plus
lens-treated eyes. TGFBIp is a secreted extracellular matrix
protein first isolated from human lung adenocarcinoma cells
following treatment with TGF-β1 [52]. Since its discovery,
TGFBIp, has been demonstrated to have a physiologic as well
as  a  pathologic  role  in  other  cell  types  including  human
melanoma  cells,  human  mammary  epithelial  cells,  human
keratinocytes,  human  foreskin  fibroblasts,  and  porcine
articular chondrocytes following stimulation with TGF-β1
[53-56] as well as in cultures of corneal epithelial cells [57,
58], primary human foreskin fibroblasts [54], human bladder
smooth  muscle  cells  [59,60],  fibroblast-like  synoviocytes
[61], and primary HSFs [62]. Depending on the cell type under
study, TGFBIp has been shown to promote [60,63-68] or
inhibit  [53,69]  cell  adhesion  through  integrin-mediated
mechanisms. Results presented here confirmed the presence
of TGFBIp protein in the cornea, choroid/RPE, and sclera of
the  marmoset  and  human  eye  and  suggest  that  TGFBIp
inhibits  scleral  fibroblast  cell  adhesion  to  poly-D-lysine-
coated plates. Similar results have been observed when HSFs
were plated on collagen type I-coated plates in the presence
of TGFBIp (unpublished). Taken together, we speculate that
increased  synthesis  of  TGFBIp  by  the  choroid/RPE  may
participate in modulating the biomechanical properties of the
sclera through alterations in cell-matrix interactions.
The  finding  that  TGFBI  expression  was  increased  in
minus lens-treated eyes relative to that of plus lens-treated
eyes  suggests  a  role  for  TGF-β  in  mediating  the  ocular
responses during visually guided ocular growth. However,
studies evaluating TGF-β in a variety of ocular tissues during
Molecular Vision 2008; 14:1465-1479 <http://www.molvis.org/molvis/v14/a175> © 2008 Molecular Vision
1475the  development  of  myopia  have  been  inconclusive.  One
study reported increased TGF-β2 in both the retina, RPE,
choroid, and sclera of myopic chicks eyes [50] while others
reported  decreased  in  TGF-β  levels  in  the  retina,  retinal
pigment epithelium, and choroid during the development of
myopia in chicks [70] as well as decreased RNA levels of the
TGF-β isoforms, TGF-β1,TGF-β2, and TGF-β3 in the tree
shrew sclera during myopia development [11].The finding of
increased TGFBI mRNA in the choroid of marmoset eyes
during  the  development  of  myopia  may  represent  a
downstream response to a TGF-β mediated cascade occurring
in the retina, choroid or sclera. Alternatively, the relative
upregulation  of  TGFBI  in  actively  elongating  eyes  may
represent a downstream response to another cytokine since
TGFBIp  has  also  been  shown  to  be  induced  by
interleukin-1β and tumor necrosis factor α in fibroblast-like
synoviocytes  isolated  from  rheumatoid  arthritis  synovial
tissue [61].
Additionally, we elected to use real-time PCR to confirm
the changes in expression of transmembrane receptor-like
protein, PTPRB, on the basis that it was one of the few genes
to be significantly downregulated in minus lens-treated eyes
as  compared  with  plus  lens-treated  eyes.  Real  time  PCR
confirmed  that  PTPRB  was  significantly  downregulated
(−54.6%) in minus lens-treated eyes as compared with plus
lens-treated eyes of the four marmosets examined. Members
of  the  PTP  family  are  highly  specific,  tightly  regulated
enzymes  with  important  regulatory  roles  that  have  been
implicated in a variety of cellular processes including cell
growth,  differentiation,  mitotic  cycle,  and  oncogenic
transformation [71-73]. Interestingly, PTPRB expression has
also been shown to regulate umbilical vein endothelial cell
migration and tube formation [74]. Based on these results, we
speculate that the relative downregulation of PTPRB in the
choroids of minus lens-treated eyes may represent a response
by choroidal vascular endothelial cells to regulate choroidal
vascularization during the development of myopia.
Several  recent  microarray  studies  have  demonstrated
significant gene expression changes in the retina or retina and
RPE following form deprivation in the macaque [75], green
monkey [75], mouse [76], and chick [39] eyes. The expression
of vasoactive intestinal peptide, cyclin A2, and hepatoma-
derived growth factor were shown to be upregulated in retinas
of form-deprived primate eyes and associated with increased
(retinal)  cell  proliferation  [75].  Analysis  of  retinal  gene
expression  changes  in  form  deprived  mouse  eyes
demonstrated  reduced  expression  of  the  immediate-early
genes  Egr-1  and  cFos  mRNA  and  temporarily  increased
expression  of  the  putative  oncogene,  Akt2  and  the  JNK
binding protein, Mapk8ip3 [76]. In contrast, analyses of chick
retina/RPE  during  the  development  of  form  deprivation
myopia demonstrated only minimal changes in retinal gene
expression, including downregulation of bone morphogenetic
protein 2, vasoactive intestinal peptide, preopro-urotensin II-
related  peptide  and  mitogen-activated  protein  kinase
phosphatase 2, and upregulation of endothelin receptor type
B and interleukin-18 [39].
Changes in RPE gene expression in response to +10 D
and −10 D lenses in young chicks have been recently reported
[26]. Among 157 upregulated genes and 632 downregulated
in minus lens-treated eyes as compared to contralateral control
eyes, the expression of TGF-β3, SMAD2, and SMAD3 was
downregulated  in  RPE  from  minus  lens-treated  eyes  as
compared with fellow eyes, whereas TGF-β receptor type I
(TGFBR1), TGF-β receptor type III (TGFBR3), somatostatin
(SST), insulin receptor substrate 1 (IRS1), and insulin-like
growth factor-binding protein 1 (IGFBP1) were shown to be
upregulated  in  RPE  from  minus-lens  treated  eyes.
Interestingly, we did not detect differences in the expression
of these genes in the choroid/RPE of binocular +/− lens-
treated marmoset eyes. It is possible that the inclusion of the
choroid in the microarray analysis of the present study may
have masked these RPE gene expression changes, if present.
However,  considering  the  differences  in  retinal  gene
expression observed during myopia development in chicks,
mice, and primates, it is also possible that the retina, RPE,
choroid, and sclera signaling cascades are distinct in chicks as
compared  with  primates,  due  to  fundamental  structural
differences in the sclera and the nature of scleral response
during visually guided ocular growth [4].
Treatment  of  young  marmosets  with  binocular  aniso-
lenses  (+5/-5  D)  was  highly  effective  in  generating  large
interocular  differences  in  vitreous  chamber  depth  and
refraction.  However,  we  acknowledge  that  this  aniso-lens
paradigm limits gene expression analyses to the identification
of relative changes in gene expression between the plus lens
and minus lens-treated eyes, rather than the identification of
specific gene expression changes associated with plus lens-
induced  and  minus  lens-induced  defocus.  We  also
acknowledge  the  technical  limitations  of  our  microarray
analysis,  which  include  the  use  of  human  primers  for
marmoset tissues, and the use of complex tissues to detect
gene  expression  changes.  As  mentioned,  some  gene
expression changes in some cell types in the choroid/RPE may
go undetected due to cancelling out by opposite changes in
gene expression by different cell types. Nevertheless, gene
expression profiling and pathway analyses of the microarray
data  obtained  from  this  study  have  identified  potential
candidate myopia genes for more focused future studies in
animal models as well as in humans and have provided a
detailed knowledge of changes in choroidal and RPE gene
expression  during  periods  of  accelerated  and  decelerated
ocular growth. This detailed knowledge will provide a basis
for understanding the molecular mechanisms underlying the
ocular response to imposed defocus and will help to elucidate
the role of the choroid/RPE in the regulation of visually guided
ocular growth.
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Appendix  1:  Differentially  expressed  genes  in  the  choroid/RPE's  of
binocular lens-treated marmoset eyes
To access the data, click or select the words “Appendix
1”. This will initiate the download of a pdf file.
Fold change was calculated as the ratio of the average
magnitude of gene expression in the minus lens-treated eyes
over  that  of  the  plus  lens-treated  eyes  (positive  numbers;
relative upregulation) or the magnitude of gene expression in
the plus lens-treated eyes over that of the minus lens-treated
eyes (negative number; relative downregulation).
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